|
TMEM57 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.058450E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.06159999996503E-06 |
| Normal-vs-Stage2 |
2.950400E-01 |
| Normal-vs-Stage3 |
8.864000E-01 |
| Normal-vs-Stage4 |
2.161000E-01 |
| Stage1-vs-Stage2 |
9.000500E-02 |
| Stage1-vs-Stage3 |
1.619970E-04 |
| Stage1-vs-Stage4 |
1.00629999999491E-06 |
| Stage2-vs-Stage3 |
3.489800E-01 |
| Stage2-vs-Stage4 |
7.575500E-02 |
| Stage3-vs-Stage4 |
2.218600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.283800E-03 |
| Normal-vs-AfricanAmerican |
6.050200E-01 |
| Normal-vs-Asian |
5.191000E-01 |
| Caucasian-vs-AfricanAmerican |
2.614400E-02 |
| Caucasian-vs-Asian |
9.970400E-01 |
| AfricanAmerican-vs-Asian |
3.684800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.035450E-01 |
| Normal-vs-Female |
9.416000E-04 |
| Male-vs-Female |
3.235800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.637600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.381740E-02 |
| Normal-vs-Age(61-80Yrs) |
2.538200E-02 |
| Normal-vs-Age(81-100Yrs) |
5.198000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.308400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.817400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.543800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.572800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.858400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.770600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.376900E-03 |
| Normal-vs-Grade 2 |
3.19119999980799E-07 |
| Normal-vs-Grade 3 |
4.200400E-01 |
| Normal-vs-Grade 4 |
2.124000E-03 |
| Grade 1-vs-Grade 2 |
4.114400E-01 |
| Grade 1-vs-Grade 3 |
9.915400E-03 |
| Grade 1-vs-Grade 4 |
1.19690000000006E-06 |
| Grade 2-vs-Grade 3 |
4.82219999997646E-06 |
| Grade 2-vs-Grade 4 |
1.2312373343093E-13 |
| Grade 3-vs-Grade 4 |
1.001130E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.31235039396915E-12 |
| Normal-vs-ccB subtype |
1.241790E-01 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.777900E-02 |
| Normal-vs-N1 |
2.825400E-01 |
| N0-vs-N1 |
1.320780E-01 |
|
|
